Regulatory Framework in Clinical Trials in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Regulatory Framework in Clinical Trials in Mexico

Regulatory Framework in Clinical Trials in Mexico – Cohortias the CRO of LATAM

Clinical trials play a crucial role in advancing medical research and the development of new treatments. However, conducting clinical trials requires a robust regulatory framework to ensure the safety and efficacy of the tested interventions. In Mexico, the regulatory framework for clinical trials has undergone significant advancements in recent years.

This blog post aims to provide an overview of the regulatory framework governing clinical trials in Mexico, highlighting key regulations, ethical considerations, and the approval process.

Regulatory Bodies and Key Legislations:

The Federal Commission for Protection against Sanitary Risks (COFEPRIS) is the primary regulatory authority responsible for overseeing clinical trials in Mexico. COFEPRIS ensures compliance with applicable laws, regulations, and international standards. Key legislations governing clinical trials in Mexico include:

  1. Mexican General Health Law: Provides the legal basis for the regulation of clinical trials, emphasizing the importance of ethical principles, informed consent, and patient safety.
  2. Official Mexican Standards (NOMs): Specific regulations issued by COFEPRIS that outline the requirements for conducting clinical trials in Mexico, including Good Clinical Practice (GCP) guidelines, adverse event reporting, and data management.

Ethical Considerations:

Protecting the rights and welfare of trial participants is paramount in clinical research. The ethical considerations in Mexican clinical trials align with internationally recognized guidelines, such as the Declaration of Helsinki. Key ethical principles include:

  1. Informed Consent: Participants must provide voluntary and informed consent after receiving comprehensive information about the trial, its risks, benefits, and their rights.
  2. Independent Ethics Committees (IECs): Every clinical trial must be reviewed and approved by an IEC, which ensures the trial’s scientific validity, ethical compliance, and participant protection.
  3. Vulnerable Populations: Special attention is given to the protection of vulnerable populations, such as minors, pregnant women, and prisoners, with additional safeguards in place to ensure their rights and well-being.

Regulatory Framework in Clinical Trials in Mexico

Regulatory Framework in Clinical Trials in Mexico

Regulatory Framework in Clinical Trials in Mexico

Approval Process:

To initiate a clinical trial in Mexico, sponsors or researchers must adhere to a well-defined approval process. Key steps in the approval process include:

  1. Submission of Clinical Trial Application: The sponsor submits a detailed application to COFEPRIS, including a study protocol, investigator qualifications, informed consent forms, and relevant documentation.
  2. Review by COFEPRIS: COFEPRIS evaluates the application for compliance with regulatory requirements, scientific validity, and ethical considerations. The review process aims to ensure patient safety and data integrity.
  3. Ethics Committee Review: Simultaneously, the trial protocol undergoes review by an IEC, which assesses the scientific and ethical aspects of the trial, ensuring participant rights are protected.
  4. Approval and Monitoring: Once both COFEPRIS and the IEC grant approval, the trial can commence. COFEPRIS conducts periodic inspections and audits to ensure compliance with regulations throughout the trial.

Post-Approval Responsibilities:

Once a clinical trial is approved, ongoing regulatory oversight and reporting obligations are necessary. Key post-approval responsibilities include:

  1. Adverse Event Reporting: Researchers and sponsors must promptly report any adverse events or unexpected safety concerns to COFEPRIS and the relevant IEC, ensuring continuous monitoring of participant safety.
  2. Data Management: Adequate documentation, data collection, and management systems must be in place to maintain the integrity and confidentiality of trial data.
  3. Trial Conclusion and Reporting: Upon completion of the trial, sponsors are required to submit comprehensive final reports to COFEPRIS, including study results, analysis, and conclusions.


Mexico’s regulatory framework for clinical trials demonstrates a commitment to ensuring patient safety, ethical conduct, and the generation of high-quality data. The alignment with international standards, the involvement of independent ethics committees, and the rigorous approval process contribute to the credibility and reliability of clinical trials conducted in Mexico.

This regulatory framework provides a solid foundation for researchers, sponsors, and participants to collaborate in advancing medical knowledge and improving patient care.

Regulatory Framework in Clinical Trials in Mexico

Source: Roche

Regulatory Framework in Clinical Trials in Mexico

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Regulatory Framework in Clinical Trials in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Regulatory Framework in Clinical Trials in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Regulatory Framework in Clinical Trials in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Regulatory Framework in Clinical Trials in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Regulatory Framework in Clinical Trials in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Regulatory Framework in Clinical Trials in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Regulatory Framework in Clinical Trials in Mexico

The Cohortias Team

Regulatory Framework in Clinical Trials in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Regulatory Framework in Clinical Trials in Mexico

Network & Partnerships